Maya Gambarin-Gelwan, M.D. – FDA Inspection, Oct 25, 2012

Record Details

This FDA Inspection record concerns Maya Gambarin-Gelwan, M.D., with an inspection on October 25, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Maya Gambarin-Gelwan, M.D.
Inspection Date: October 25, 2012
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · cb612218-46ca-4e93-aab9-f9ba446351f4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 804108
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Maya Gambarin-Gelwan, M.D.

FDA Inspection

Maya Gambarin-Gelwan, M.D.October 25, 2012